In order to determine whether the development of psychosis and worsened prognosis in AD is associated with an increased burden of tau pathology that can be identified with tau imaging, we compared baseline [18F]-AV1451 retention together with cognitive and functional decline in those who became psychotic over the course of participation in ADNI with those who did not. This evidence concerns the gene MAPT and Alzheimer disease.